Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Levitsky Hyam Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:34 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 170,000 | $0 | 706,544 (Direct) | View |
2023-04-12 Option Award | 2023-04-14 7:56 pm | N/A 2033-04-12 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 131,250 | $0 | 131,250 (Direct) | View |
Ownership | 2023-04-14 7:55 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 0 | $0 | 570,660 (Indirect) | View |
2023-04-01 Option Award | 2023-04-04 8:03 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Levitsky Hyam Director | 25,200 | $0 | 25,200 (Direct) | View |
2022-04-01 Option Award | 2022-04-05 4:08 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Levitsky Hyam Director | 16,500 | $0 | 16,500 (Direct) | View |
2022-01-25 Option Award | 2022-01-27 4:50 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 105,000 | $0 | 105,000 (Direct) | View |
Ownership | 2021-06-17 4:59 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 0 | $0 | 556,416 (Indirect) | View |
2021-04-01 Option Award | 2021-04-05 8:15 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Levitsky Hyam Director | 16,500 | $0 | 16,500 (Direct) | View |
2020-04-01 Option Award | 2020-04-02 4:32 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Levitsky Hyam Director | 16,500 | $0 | 16,500 (Direct) | View |